NFKB1 and cancer: It has recently been shown that NF-κB signaling can drive GBM cancer stem cells28, but surprisingly, no data is available in the GBM microenvironment, and it is not understood whether the canonical NF-κB pathway has a proinflammatory or anti-inflammatory role in GBM tumor recruited myeloid cell populations.